Introduction
There are known sex differences in neurological function such as lower prevalence of mild cognitive impairment among women (1) , but higher prevalence of depression (2) . It has been speculated that estrogen, the female sex hormone, may explain these differences as estrogen may improve neural plasticity and the health of the neurovascular unit (3), but may also modulate mood via the serotonergic system (3) . Observational studies consistently showed that hormone replacement therapy (HRT) users had a lower risk of dementia (3), but less so for depression (3), than non-users. The subsequent Women's Health Initiative Memory Study (WHIMS) showed HRT had adverse effect on cognition (4), whilst findings from trials of estrogen or HRT for depression have been inconsistent (5) (6) (7) . HRT users differed from non-users in terms of socioeconomic position and lifestyle, so unmeasured confounding may explain the discrepant results between these two study designs (8) . However, the response to HRT could depend on the timing of initiation, a phenomenon known as the timing hypothesis (3, 9) . Specifically, HRT initiated around the time of menopause may improve cognition but reduce cognition if HRT is initiated years after menopause. Different HRT formulations (as estrone, estradiol or estradiol with progesterone) may also have different effects on cognitive function (3) . Replication using an alternative design, comparing cognition and depression in women with genetically determined differences in estrogen, may help elucidate the role of estrogen. A separate sample Mendelian randomization study, which utilizes genetic predictors of the exposure, in this case estrogen, may be an alternative for several reasons. First, genetic make-up is randomly allocated at conception analogous to the randomization process in randomized controlled trials (RCTs), giving estimates of association that are less susceptible to the unmeasured confounding that may bias observational studies (10) . Mendelian randomization has increasingly been used to ascertain A C C E P T E D M A N U S C R I P T
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whether risk factors for poor cognitive function, such as lipids and alcohol use, are causal (11, 12) . Second, Mendelian randomization studies assess lifelong effects which is potentially more relevant to the timing hypothesis than randomized controlled trials where mainly postmenopausal women were recruited (4). On the other hand, unlike randomized controlled trials which assess the effect of exogenous exposures, Mendelian randomization studies assess the effect of endogenous exposure, and hence may be less susceptible to problems such as pleiotropic effect of interventions used in RCTs (13) . Third, a separate sample Mendelian randomization study allows estimates of effects where the genetic association for the exposure comes from a different sample than the genetic associations for the outcome, which is a more efficient and less biased design (14) that enables estimation of lifelong effects of an exposure, such as estrogen that changes with age. Genetic determinants of estrogen exposure in young women may be used to determine the effects of estrogen in older women because it is less susceptible to measurement error (15) , and so may give more reliable estimates (14) . We have previously used this approach to examine the role of testosterone and estrogen in cardiovascular disease risk factors and inflammation (16) (17) (18) . In this study, we examined the relation of lifelong exposure to estrogen with cognition and depressive symptoms using a Mendelian randomization study among Southern Chinese women to clarify the role of lifelong estrogen exposure.
Methods
Sources of data (20) . Cognitive function was assessed using the test
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of new learning ability (10-word list learning task) from a test battery developed for the Consortium to Establish a Registry for Alzheimer's Disease (21). Four words "pole", "shore", "cabin", and "engine" were replaced with "corner", "stone", "book", and "stick" as in the adapted Consortium 10-word list learning task (22) , and "butter" and "queen" were replaced by "soy sauce" and "chairman" as these are more culturally appropriate. During the learning phase, the 10-word list was read out to the participant who was then asked to recall immediately the words they remembered; this was repeated 3 times. After a 5-minute period of distraction, during which the interview was continued, the participant was then asked to recall as many of the 10 words as he or she was able, giving the delayed recall score out of 10. In phase 3 and the subsequent follow up for all phases, we additionally used the Mini Mental State Examination (MMSE) (23) . Three of the 11 tasks in the original MMSE were modified to be culturally appropriate and consistent with other adaptations for Chinese populations (24) . Orientation in place was adapted according to geographical divisions of China and screening setting to:
"country", "province", "city", "hospital", and "floor". In the 3-word registration and recall "table"
and "penny" were replaced by "newspaper" and "train", while the third word remained as "apple", to ensure all three words were frequently used two-character Chinese words. The modified MMSE has the same scale as the original MMSE (24) , hence the psychometric properties of the measures should be similar. Depressive symptoms were assessed by the Chinese version of the 15-item Geriatric Depression Scale (GDS) which has been used before in Chinese (25) .
Fasting blood samples were collected at baseline recruitment in phase 3 or at follow up for participants recruited in other phases. Samples were stored, as whole blood or as buffy coat and
sera, at -80 0 C for all apart from a subset of phase 3 participants whose DNA was extracted from fresh blood and stored at -80 0 C (12). was considered failure. All SNPs passed with a call rate >95%.

Exposure
The exposure was genetically predicted log 17β-estradiol (pmol/L).
Outcome
The outcomes were delayed 10-word recall test score and modified MMSE score for cognitive function, and GDS score for depressive symptoms. The adapted Consortium 10-word list learning task has been validated as a culturally and educationally sensitive tool for identifying dementia in population-based research in developing countries (22) . The modified MMSE has been used before (31) (32) (33) . The delayed 10-word recall test, MMSE and GDS were also administered to all participants (phases 1-3) at follow up, so we used the test scores from follow up for those without baseline test scores, because MMSE and GDS was not administered at baseline in phases 1 and 2.
Statistical analysis
In the sample of young Chinese women from Hong Kong, we established genetic predictors of log 17β-estradiol based on 2 SNPs from stepwise linear regression starting with 5 SNPs with replication in 1,000 bootstrapping samples, as described previously (17) . In the GBCS sample, we tested for Hardy-Weinberg equilibrium at the SNP locus on a contingency table of observedversus-predicted frequencies with an exact test. We used ANOVA to assess whether genetically predicted log 17β-estradiol was associated with potential confounders We used separate sample instrumental variable analysis to estimate the association of log 17β-estradiol with cognitive
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function and depressive symptoms in the sample of older Chinese women from GBCS by using suest (seemingly unrelated regression command in Stata) to generate the Wald estimates from the ratio of the association of genetic determinants of log 17β-estradiol with cognitive function and depressive symptoms in GBCS and the association of genetic determinants of log 17β-estradiol with log 17β-estradiol in the sample of young women (34) . Figure 1 shows the flow chart of the study.
All statistical analyses were conducted using Stata 13.1 (StataCorp LP, College Station, Texas, USA).
Results
Among the young Chinese women samples (n=236, one participant was excluded because of invalid 17β-estradiol), the F-statistic for genetically predicted log 17β-estradiol was 13.2, with an adjusted R 2 of 4.9%, suggesting that the analyses is unlikely to be susceptible to weak instrument bias. Among the 22,067 women in all 3 phases of GBCS, SNP analysis was available for 3,316 women, with availability depending on the phase of recruitment and other logistical concerns.
Among these 3,316 women, 3,096 (93.4%) had all selected SNPs. However, these women were more likely to have a higher education level and to have had non-manual jobs (Appendix 1).The 2 SNPs used to generate the genetic score did not deviate from the Hardy Weinberg equilibrium (p=0.42 for rs1008805; and p=0.73 for rs2175898) in the GBCS sample. Of the 3,096 women, 1,821 had MMSE from baseline and 1,245 from follow-up, 1,824 had GDS from baseline and 1,261 from follow-up and 2,943 had delayed 10 word recall from baseline and 143 from follow up. Table 1 shows genetically predicted log 17β-estradiol, obtained from a previously derived
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genetic prediction rule ((0.1×rs1008805-0.1×rs2175898+4.7) (17), was unrelated to age, smoking, alcohol use, physical activity, education and longest held occupation among older Southern Chinese women from GBCS. 
Discussion
This study, to our knowledge, is the first study to examine the effect of lifelong exposure to estrogen on cognitive function or depressive symptoms using a separate sample Mendelian randomization design. This study adds by showing that there is no evidence for any protective effect of estrogen on cognitive function, consistent with the WHIMS and other RCTs (4, 35), or on depressive symptoms, consistent with RCTs (5, 6). By replicating the findings from previous RCTs, this study also demonstrates the utility of the Mendelian randomization study design as a useful alternative or, ideally, precursor to RCTs.
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Although we used a separate sample Mendelian randomization design which is less susceptible to the confounding often found in observational studies, limitations exist. First, as with all study designs, Mendelian randomization has assumptions which are not always testable. Specifically, we are unable to assess if the genetic variants affected cognitive function or depressive symptoms only via their associations with estrogen, i.e. the exclusion restriction criteria, as we did not have genetic variants, estrogen, and the outcomes all measured for the same women.
Second, we did not use estrogen related genetic variants from genome wide association studies (GWAS), because no such studies have reliably identified estrogen related genetic polymorphisms in Chinese women. Therefore, we have established our own genetic prediction rule in a young Chinese women sample using stepwise regressions and bootstrapping methods, as described previously. (17) Mendelian randomization is susceptible to confounding by population stratification but the participants had the same genetic origin. Fourth, our study was powered to detect a change of 0.23 standard deviation in the outcomes, for example an MMSE score of 0.8 per increase in one log unit change in estrogen (pmol/L). We could not detect smaller changes due to estrogen which could be important to population health but possibly are less clinically relevant. Fifth, women who did not return for follow up had lower socioeconomic position than those who returned for follow up (36) . Furthermore, some participants were chosen based on their change in cognitive function from baseline for a case control study examining genetic determinants of cognitive function (37) . However, selection bias would only occur if those with a specific relation of estrogen related genetic variants with cognitive function or depressive symptoms did not return or were included in the case control study, which is unlikely. Moreover, a sensitivity analysis excluding the women cases gave very similar estimates (data not shown). Lastly, our study only focused on estrogen and may not be relevant
to the effect of combined treatment (i.e. estrogen and progestin). However, the WHIMS showed combined treatment did not prevent cognitive impairment (38) . The Kronos Early Estrogen Prevention Study (KEEPS) showed positive effect of HRT on mood although only for those receiving oral treatment (39) , whether comparing effects by formulation for mood was part of the original protocol is unclear (39) .
The discrepancies between observational studies and RCTs could be an indicator of confounding by healthier attributes among users compared to non-users of HRT in observational studies (8, 35) . Notwithstanding this likely explanation, alternative explanations such as the timing hypothesis may explain this discrepancy (9), in particular WHIMS mainly recruited participants several years after their menopause (4). The null findings from our study, which examined the lifelong effect of estrogen, do not provide evidence in support of the timing hypothesis and is consistent with the WHIMS analysis restricting to participants aged 50-55 (40) . Similarly, our null findings on estrogen and depressive symptoms are consistent with the more recent RCTs (5, 6) . Taking these studies together suggests no strong protective effect of estrogen on long term cognitive function or depressive symptoms in the general population.
Our study adds evidence concerning the effect of estrogen on cognitive function and depressive symptoms using separate sample Mendelian randomization, and there is no strong evidence for an effect or evidence for the timing hypothesis although the issue of statistical power may account for the lack of evidence. However, replication in a larger Mendelian randomization study may examine the possibility of smaller effects of estrogen on these outcomes, with
corresponding implications for public health and clinical practice, assuming the benefits outweigh any risks. 
